{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:28:18Z","timestamp":1768076898209,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:00:00Z","timestamp":1507680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["SFB704"],"award-info":[{"award-number":["SFB704"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["GRK 2168"],"award-info":[{"award-number":["GRK 2168"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bonn Cluster of Excellence \u201cImmunoSensation.\u201d"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ymthe.2017.10.005","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T08:52:52Z","timestamp":1507971172000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["RNA Aptamers Recognizing Murine CCL17 Inhibit T Cell Chemotaxis and Reduce Contact Hypersensitivity In\u00a0Vivo"],"prefix":"10.1016","volume":"26","author":[{"given":"Lorenz","family":"F\u00fclle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Funke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Gondorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Siegl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike V.","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana K.","family":"Ha\u00dfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Belen","family":"Erazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Schanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. James","family":"Stunden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Gr\u00f6ber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"H\u00e4ndler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Weighardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eicke","family":"Latz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim L.","family":"Schultze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irmgard","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt B","key":"10.1016\/j.ymthe.2017.10.005_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejphar.2015.05.018","article-title":"Targeting chemokine receptors in disease--a case study of CCR4","volume":"763","author":"Solari","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2017.10.005_bib3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2017.10.005_bib4","doi-asserted-by":"crossref","first-page":"21514","DOI":"10.1074\/jbc.271.35.21514","article-title":"Molecular cloning of a novel T\u00a0cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector","volume":"271","author":"Imai","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2017.10.005_bib5","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2684::AID-IMMU2684>3.0.CO;2-Y","article-title":"The murine beta-chemokine TARC is expressed by subsets of dendritic cells and attracts primed CD4+ T\u00a0cells","volume":"29","author":"Lieberam","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.20021859","article-title":"Compartmentalized production of CCL17 in\u00a0vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen","volume":"197","author":"Alferink","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2017.10.005_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ni.1848","article-title":"Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs","volume":"11","author":"Semmling","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib8","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1073\/pnas.0906126107","article-title":"Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells","volume":"107","author":"Stutte","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.10.005_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib11","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.4049\/jimmunol.1302175","article-title":"Cutting edge: identification of the thymic stromal lymphopoietin-responsive dendritic cell subset critical for initiation of type 2 contact hypersensitivity","volume":"191","author":"Kitajima","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib12","series-title":"Atopic Dermatitis \u2013 Disease Etiology and Clinical Management","first-page":"81","article-title":"Expression and function of CCL17 in atopic dermatitis","author":"Stutte","year":"2012"},{"key":"10.1016\/j.ymthe.2017.10.005_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2011.10.027","article-title":"CCL17 promotes intestinal inflammation in mice and counteracts regulatory T\u00a0cell-mediated protection from colitis","volume":"142","author":"Heiseke","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2017.10.005_bib14","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1172\/JCI44925","article-title":"CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T\u00a0cell homeostasis in mice","volume":"121","author":"Weber","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2017.10.005_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1346-8138.12440","article-title":"Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis","volume":"41","author":"Kataoka","year":"2014","journal-title":"J.\u00a0Dermatol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ACI.0b013e32831f8ee0","article-title":"Novel biomarkers in asthma: chemokines and chitinase-like proteins","volume":"9","author":"Hartl","year":"2009","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/dxu079","article-title":"CCR4 and its ligands: from bench to bedside","volume":"27","author":"Yoshie","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajh.23361","article-title":"Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma","volume":"88","author":"Sauer","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib19","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1172\/JCI87828","article-title":"Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation","volume":"126","author":"Achuthan","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2017.10.005_bib20","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T\u00a0cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2017.10.005_bib21","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.4049\/jimmunol.1300232","article-title":"Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy","volume":"192","author":"Viney","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2014.02.007","article-title":"Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists","volume":"729","author":"Ajram","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/eji.200324429","article-title":"Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells","volume":"34","author":"Mariani","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2017.10.005_bib25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.chembiol.2014.08.003","article-title":"Aptamers and SELEX in chemistry & biology","volume":"21","author":"Famulok","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib26","doi-asserted-by":"crossref","first-page":"20556","DOI":"10.1074\/jbc.273.32.20556","article-title":"2\u2032-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain","volume":"273","author":"Ruckman","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2017.10.005_bib27","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.10.005_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejps.2012.10.014","article-title":"Therapeutic RNA aptamers in clinical trials","volume":"48","author":"Sundaram","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ymthe.2017.10.005_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5483\/BMBRep.2015.48.4.277","article-title":"Therapeutic aptamers: developmental potential as anticancer drugs","volume":"48","author":"Lee","year":"2015","journal-title":"BMB Rep."},{"key":"10.1016\/j.ymthe.2017.10.005_bib30","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood-2013-03-493924","article-title":"The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization","volume":"123","author":"Hoellenriegel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2017.10.005_bib31","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1038\/ncomms7923","article-title":"Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2","volume":"6","author":"Oberth\u00fcr","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2017.10.005_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nchembio.277","article-title":"In\u00a0vivo selection of tumor-targeting RNA motifs","volume":"6","author":"Mi","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2017.10.005_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-3197-2_7","article-title":"Next-generation analysis of deep sequencing data: bringing light into the black box of SELEX experiments","volume":"1380","author":"Blank","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib35","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1038\/mtna.2014.74","article-title":"Aptamer selection technology and recent advances","volume":"4","author":"Blind","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2017.10.005_bib36","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/nar\/gkg595","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2017.10.005_bib37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.immuni.2013.05.004","article-title":"Immune sensing of DNA","volume":"38","author":"Paludan","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2017.10.005_bib38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nri3446","article-title":"The history of Toll-like receptors - redefining innate immunity","volume":"13","author":"O\u2019Neill","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/jid.2012.284","article-title":"Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis","volume":"133","author":"Honda","year":"2013","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib40","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.183.3.1001","volume":"183","author":"Xu","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2017.10.005_bib41","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1182\/blood-2011-01-329656","article-title":"A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T\u00a0cells and tumor immunity against self antigens","volume":"118","author":"Pere","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2017.10.005_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tips.2014.02.003","article-title":"Targeting CCR4 as an emerging strategy for cancer therapy and vaccines","volume":"35","author":"Bayry","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2017.10.005_bib43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib44","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1158\/1535-7163.MCT-12-0278","article-title":"Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells","volume":"11","author":"Chang","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2017.10.005_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.194.6.847","article-title":"Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T\u00a0cells","volume":"194","author":"Iellem","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2017.10.005_bib46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/cas.12116","article-title":"Stevens-Johnson syndrome associated with mogamulizumab treatment of adult T-cell leukemia\/ lymphoma","volume":"104","author":"Ishida","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ymthe.2017.10.005_bib47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0625.2007.00630.x","article-title":"CCR4 and CCR10 ligands play additive roles in mouse contact hypersensitivity","volume":"17","author":"Mirshahpanah","year":"2008","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2133.2009.09552.x","article-title":"Visualizing CD4 T-cell migration into inflamed skin and its inhibition by CCR4\/CCR10 blockades using in\u00a0vivo imaging model","volume":"162","author":"Wang","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib49","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1038\/jid.2010.208","article-title":"Absence of\u00a0CCR4 exacerbates skin inflammation in an oxazolone-induced contact hypersensitivity model","volume":"130","author":"Lehtim\u00e4ki","year":"2010","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib50","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.194.10.1541","article-title":"CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T\u00a0cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin","volume":"194","author":"Reiss","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2017.10.005_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nri3150","article-title":"Early immune events in the induction of allergic contact dermatitis","volume":"12","author":"Kaplan","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib52","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ni.2992","article-title":"Perivascular leukocyte clusters are essential for efficient activation of effector T\u00a0cells in the skin","volume":"15","author":"Natsuaki","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2017.10.005_bib53","doi-asserted-by":"crossref","first-page":"14746","DOI":"10.1038\/srep14746","article-title":"A strategy to discover decoy chemokine ligands with an anti-inflammatory activity","volume":"5","author":"Abboud","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2017.10.005_bib54","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1107\/S0907444903009454","article-title":"Structures of thymus and activation-regulated chemokine (TARC)","volume":"59","author":"Asojo","year":"2003","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ymthe.2017.10.005_bib55","unstructured":"NoxxonPharma. (2012). NOXXON initiates phase IIa of anti-CCL2\/MCP-1 Spiegelmer\u00ae NOX-E36 for treatment of diabetic nephropathy. June 19, 2012. https:\/\/www.noxxon.com\/downloads\/pressrel\/2012-06-19_NOXXON_Initiates_Phase_IIa_of_Spiegelmer_NOX-E36.pdf."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161730521X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161730521X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T19:42:13Z","timestamp":1719517333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500161730521X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S152500161730521X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.10.005","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA Aptamers Recognizing Murine CCL17 Inhibit T Cell Chemotaxis and Reduce Contact Hypersensitivity In\u00a0Vivo","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s).","name":"copyright","label":"Copyright"}]}}